Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Atalanta Raises $97m To Advance RNAi Therapies For Epilepsy And Huntington’s

30 Jan 2025

• By Andrew McConaghie

Neon sign shaped like a brain — • Source: Shutterstock

Related Content

Novartis Excited About Iptacopan But Downcast After Huntington’s Blow

02 Feb 2023

Related Companies

Atalanta Therapeutics

Ionis Pharmaceuticals, Inc.

More from Financing

More from Start-Ups & SMEs

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.